Related references
Note: Only part of the references are listed.YRNA Expression Profiles are Altered in Clear Cell Renal Cell Carcinoma
Malin Nientiedt et al.
EUROPEAN UROLOGY FOCUS (2018)
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu et al.
NATURE (2017)
CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma
Shufeng Zhou et al.
ONCOTARGET (2017)
Total Extracellular Small RNA Profiles from Plasma, Saliva, and Urine of Healthy Subjects
Ashish Yeri et al.
SCIENTIFIC REPORTS (2017)
Variety of RNAs in Peripheral Blood Cells, Plasma, and Plasma Fractions
Anna V. Savelyeva et al.
BIOMED RESEARCH INTERNATIONAL (2017)
miR-134: A Human Cancer Suppressor?
Jing-Yu Pan et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
High Throughput Sequencing of Extracellular RNA from Human Plasma
Kirsty M. Danielson et al.
PLOS ONE (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Comprehensive evaluation of extracellular small RNA isolation methods from serum in high throughput sequencing
Yan Guo et al.
BMC GENOMICS (2017)
Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR
Francesco Marabita et al.
BRIEFINGS IN BIOINFORMATICS (2016)
High-throughput sequencing of human plasma RNA by using thermostable group II intron reverse transcriptases
Yidan Qin et al.
RNA (2016)
Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma
Virginie Armand-Labit et al.
ACTA DERMATO-VENEREOLOGICA (2016)
RASopathy Gene Mutations in Melanoma
Ruth Halaban et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis
Sen Guo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma
Pierre L. Triozzi et al.
CLINICAL EPIGENETICS (2016)
Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations
Nalini Venkatesan et al.
PLOS ONE (2016)
Plasma extracellular RNA profiles in healthy and cancer patients
Tiezheng Yuan et al.
SCIENTIFIC REPORTS (2016)
Functional roles of non-coding Y RNAs
Madzia P. Kowalski et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids
Marta Fernandez-Mercado et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma
Zanxi Fang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition
Ronan Russell et al.
NATURE COMMUNICATIONS (2015)
Bias in Ligation-Based Small RNA Sequencing Library Construction Is Determined by Adaptor and RNA Structure
Ryan T. Fuchs et al.
PLOS ONE (2015)
U6 is not a suitable endogenous control for the quantification of circulating microRNAs
Mengqin Xiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
The E3 Ubiquitin Ligase AMFR and INSIG1 Bridge the Activation of TBK1 Kinase by Modifying the Adaptor STING
Qiang Wang et al.
IMMUNITY (2014)
Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
Pippa G. Corrie et al.
LANCET ONCOLOGY (2014)
Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma
Shan-Shan Liu et al.
BIOMEDICAL REPORTS (2014)
Improved workflows for high throughput library preparation using the transposome-based nextera system
Sarah Lamble et al.
BMC BIOTECHNOLOGY (2013)
Plasma MicroRNA-21 Is Associated with Tumor Burden in Cutaneous Melanoma
Gerald Saldanha et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Taming the Wild-Types: Targeting PAK1 in Melanomas That Lack BRAF Mutations
Keiran S. M. Smalley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab
Aubrey G. Wagenseller et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Sensitive detection of melanoma metastasis using circulating microRNA expression profiles
Rie Shiiyama et al.
MELANOMA RESEARCH (2013)
The UCSC Genome Browser database: extensions and updates 2013
Laurence R. Meyer et al.
NUCLEIC ACIDS RESEARCH (2013)
NextGen Sequencing Technology-based Dissection of Physiological Systems 5′-YRNA fragments derived by processing of transcripts from specific YRNA genes and pseudogenes are abundant in human serum and plasma
Joseph M. Dhahbi et al.
PHYSIOLOGICAL GENOMICS (2013)
In-Depth Characterization of microRNA Transcriptome in Melanoma
James Kozubek et al.
PLOS ONE (2013)
Assessing an Improved Protocol for Plasma microRNA Extraction
Ines Moret et al.
PLOS ONE (2013)
High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma
Makoto Emori et al.
PLOS ONE (2013)
Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study
Qian Xu et al.
BMC CLINICAL PATHOLOGY (2013)
Melanoma incidence and mortality in Europe: new estimates, persistent disparities
A. M. Forsea et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
GENCODE: The reference human genome annotation for The ENCODE Project
Jennifer Harrow et al.
GENOME RESEARCH (2012)
Serum microRNAs as biomarkers for recurrence in melanoma
Erica B. Friedman et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Reference Genes for Real-Time PCR Quantification of MicroRNAs and Messenger RNAs in Rat Models of Hepatotoxicity
Maria N. Lardizabal et al.
PLOS ONE (2012)
Dynamic interaction of Y RNAs with chromatin and initiation proteins during human DNA replication
Alice Tianbu Zhang et al.
JOURNAL OF CELL SCIENCE (2011)
Emerging roles for the Ro 60-kDa autoantigen in noncoding RNA metabolism
Soyeong Sim et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2011)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
Iris Helfrich et al.
CLINICAL CANCER RESEARCH (2009)
Noncoding human Y RNAs are overexpressed in tumours and required for cell proliferation
C. P. Christov et al.
BRITISH JOURNAL OF CANCER (2008)
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
Charles H. Lawrie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Clinical value of combined determination of plasma L-DOPA/tyrosine ratio, S100B, MIA and LDH in melanoma
Jean-Pierre Garnier et al.
EUROPEAN JOURNAL OF CANCER (2007)
Functional requirement of noncoding Y RNAs for human chromosomal DNA replication
Christo P. Christov et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Structural insights into RNA quality control: The Ro autoantigen binds misfolded RNAs via its central cavity
AJ Stein et al.
CELL (2005)
Expression and function of the AMF receptor by human melanoma in experimental and clinical systems
J Timar et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum
SY Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)